We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+4.14%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.1B
AUM Growth
–
Cap. Flow
+$20.8B
Cap. Flow
% of AUM
98.76%
Top 10 Holdings %
Top 10 Hldgs %
26.91%
Holding
1,431
New
1,431
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.1B |
| 2 |
Apple
AAPL
|
+$895M |
| 3 |
Microsoft
MSFT
|
+$781M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$593M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$523M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.88% |
| 2 | Financials | 10.47% |
| 3 | Healthcare | 9.59% |
| 4 | Consumer Discretionary | 7.62% |
| 5 | Industrials | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Sherwin-Williams
SHW
$80.7B
| $58.7M | 0.28% |
+181,015
| New | +$60.6M |
|
|
EAGL
77
Eagle Capital Select Equity ETF
EAGL
$4.37B
| $56.8M | 0.27% |
+1,751,300
| New | +$55.8M |
|
78
Martin Marietta Materials
MLM
$34.3B
| $55.4M | 0.26% |
+89,030
| New | +$55.4M |
|
79
Merck
MRK
$323B
| $55.2M | 0.26% |
+524,371
| New | +$49.2M |
|
80
NetApp
NTAP
$33.3B
| $54.8M | 0.26% |
+512,023
| New | +$58.5M |
|
81
Incyte
INCY
$23.7B
| $54.2M | 0.26% |
+549,006
| New | +$53.1M |
|
82
Colgate-Palmolive
CL
$73.6B
| $50.7M | 0.24% |
+642,211
| New | +$50.4M |
|
83
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.25B
| $49.9M | 0.24% |
+353,595
| New | +$50M |
|
84
Progressive
PGR
$125B
| $49.8M | 0.24% |
+218,816
| New | +$49.4M |
|
85
UnitedHealth
UNH
$379B
| $49.8M | 0.24% |
+150,940
| New | +$51.2M |
|
86
Thermo Fisher Scientific
TMO
$208B
| $49.5M | 0.23% |
+85,457
| New | +$48.3M |
|
87
KLA
KLAC
$266B
| $49.1M | 0.23% |
+404,300
| New | +$47.4M |
|
88
Medtronic
MDT
$108B
| $47.5M | 0.23% |
+494,743
| New | +$48.1M |
|
89
IQVIA
IQV
$35.6B
| $45M | 0.21% |
+199,650
| New | +$43.4M |
|
90
Okta
OKTA
$23.9B
| $43.7M | 0.21% |
+505,623
| New | +$44.1M |
|
91
iShares MSCI USA Quality Factor ETF
QUAL
$46B
| $43.1M | 0.2% |
+217,142
| New | +$42.7M |
|
92
Walt Disney
DIS
$168B
| $42.6M | 0.2% |
+374,280
| New | +$41.2M |
|
93
Qualcomm
QCOM
$179B
| $42.4M | 0.2% |
+247,626
| New | +$42.4M |
|
94
Amgen
AMGN
$203B
| $42.1M | 0.2% |
+128,476
| New | +$40.8M |
|
95
Williams-Sonoma
WSM
$27.6B
| $41.2M | 0.2% |
+230,934
| New | +$43.3M |
|
96
Vanguard Mid-Cap ETF
VO
$107B
| $41.1M | 0.19% |
+566,152
| New | +$41.2M |
|
97
GE Aerospace
GE
$375B
| $40.9M | 0.19% |
+132,819
| New | +$40M |
|
98
Bank of America
BAC
$436B
| $40.8M | 0.19% |
+742,258
| New | +$39.2M |
|
99
Cencora
COR
$60.5B
| $40.6M | 0.19% |
+120,071
| New | +$40.9M |
|
100
iShares MSCI USA Min Vol Factor ETF
USMV
$23.4B
| $40.1M | 0.19% |
+425,429
| New | +$40.1M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for Glenmede Trust, which disclosed 1,431 positions worth $21.1B. Its ten largest holdings account for 27% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 1,772,161 shares worth $1.11B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, followed by Financials and Healthcare.
- Glenmede Trust's largest Q4 2025 buy was Vanguard S&P 500 ETF: 1,772,161 shares worth $1.11B.
- Glenmede Trust's ten largest holdings make up 27% of its $21.1B portfolio in Q4 2025.
- Glenmede Trust disclosed 1,431 positions in Q4 2025, its first 13F filing on record.
Based on Glenmede Trust's 13F filing for Q4 2025, filed 17 Feb 2026.